ArticleHuman vaccines & immunotherapeutics2023
A retrospective audit of neonatal BCG vaccination in Grampian, Scotland.
Article in Human vaccines & immunotherapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
- Revamping the BCG revaccination strategy: Records to recall, or just call it phoenix?Human vaccines & immunotherapeutics · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacillus Calmette-Guerin (BCG) vaccine confers protection against tuberculosis (TB) and works most effectively when given to infants. Scotland runs a risk-based program in which BCG vaccine is offered to infants whose parent or grandparent was born in a high incidence country for TB. BCG vaccination records for all infants born in Grampian from 1st January 2019 to 31st December 2021 were reviewed from Nov 2022 to Feb 2023. Three electronic databases were examined, i.e. BadgerNet, Scottish Immunisation Recall System and TrakCare. Data were analyzed using Microsoft Excel 2013. Out of a total of 16,078 live births in the 3-year study period, 2060 met the criteria for offering BCG vaccination. The uptake level was 93% in 2019, 89% in 2020 (in the midst of the COVID-19 pandemic) and 93% in 2021. Audit results demonstrated higher uptake than the 85% key performance indicator target within the 2018 Scottish TB Framework and improvement in vaccination rates as compared to earlier rates of 86% in 2012 and 90% in 2013 in Grampian. Strengthening electronic systems and enhancing awareness regarding TB and the BCG vaccine can further progress BCG vaccination uptake.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.